SOD1 for Neurodegenerative Disease Research
StressMarq has developed unique Superoxide Dismutase 1 (SOD1) Pre-formed Fibrils (PFFs) and monomers for neurodegenerative disease research, particularly valuable for
Read moreStressMarq has developed unique Superoxide Dismutase 1 (SOD1) Pre-formed Fibrils (PFFs) and monomers for neurodegenerative disease research, particularly valuable for
Read moreStressMarq has developed unique Transthyretin (TTR) Filaments and Monomers designed to propel research on TTR and its association with amyloid
Read moreStressMarq has developed unique alpha synuclein constructs to provide invaluable support to researchers engaged in disease model development and the
Read moreStressMarq is a pioneer in the development of tau proteins that facilitate the investigation of tau aggregation, a key characteristic
Read moreParkinson’s Disease is characterized by the aggregation of alpha-synuclein, a key pathological feature. In this informative video, the mechanism underlying
Read moreTau is a key protein implicated in neurodegenerative diseases, such as Alzheimer’s and dementia. Tau Pre-formed Fibrils (PFFs) for Modelling
Read moreSonification: What, Why, How and Best Practices A StressMarq Biosciences .pdf White Paper Neurodegenerative Disease Research As populations age, the
Read moreNeuroscience is an interdisciplinary science devoted to the study of the nervous system’s structure and function. A StressMarq Biosciences .pdf
Read moreCoya Therapeutics’ investigational low-dose interleukin-2 (IL-2) for subcutaneous administration, COYA 301, has been found to increase Treg function and halt
Read moreAccording to a recent UK population-based study published in The Lancet, approximately one in ten individuals are now affected by
Read more